Identifying appropriate patients to treat: a case-based approach.

ESC Premium Access

Identifying appropriate patients to treat: a case-based approach.

Session: PSCK9 inhibition: a new horizon in LDL-C management

Topic: Lipids

Speaker: Professor C. Cannon (Boston, US) Professor A. Catapano (Milan, IT) Professor S. Nicholls (Melbourne, AU) Doctor P. Ridker (Boston, US) Doctor J. Robinson (Iowa, US)

About the speakers

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)

38 presentations

0 follower

Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)

47 presentations

3 followers

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

53 presentations

5 followers

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

37 presentations

7 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)

12 presentations

0 follower

6 more presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor C. Cannon (Boston, US)

Access

LDL-C exposure and atherosclerosis progression.

Speaker: Professor A. Catapano (Milan, IT)

Access

PCSK9 inhibition: the data today and tomorrow.

Speaker: Professor S. Nicholls (Melbourne, AU)

Access

Learnings and clinical insights from SPIRE.

Speaker: Doctor P. Ridker (Boston, US)

Access

Guidelines: commonalities and discrepancies.

Speaker: Doctor J. Robinson (Iowa, US)

Access

Access the full session

PSCK9 inhibition: a new horizon in LDL-C management

Speakers: Professor C. Cannon, Professor A. Catapano, Professor S. Nicholls, Doctor P. Ridker, Doctor J. Robinson...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources